Framingham, MA, United States of America

Marshall Lee Morningstar

This inventor holds 11 USPTO granted patents and 18 published patent applications and 4 EPO patents. Top assignee: Sage Therapeutics, Inc.. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marshall Lee Morningstar. Retrieved from https://idiyas.com/inventor/marshall-lee-morningstar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 18)

% Patents Active = 100.0

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 20(Granted Patents)

Company Filing History:

11 out of 99

Sage Therapeutics, Inc.

patents

Years Active: 2023-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12686700 - Neuroactive steroids substituted in position 10 with a cyclic group for use in the treatment of CNS disorders (2026-07-21),

2. 12673970 - Neuroactive steroids and their methods of use (2026-07-07),

3. 12552829 - Compositions and methods for treating CNS disorders (2026-02-17),

4. 12410210 - Neuroactive steroids and their methods of use (2025-09-09),

5. 12264177 - Neuroactive steroids and their methods of use (2025-04-01),

6. 12252509 - Neuroactive steroids and their methods of use (2025-03-18),

7. 11999765 - Neuroactive steroids and their methods of use (2024-06-04),

8. 11970514 - Neuroactive steroids and their methods of use (2024-04-30),

9. 11912738 - Neuroactive steroids and their methods of use (2024-02-27),

10. 11643434 - Neuroactive steroids and compositions thereof (2023-05-09),

11. 11634453 - Neuroactive steroids substituted in position 10 with a cyclic group for use in the treatment of CNS disorders (2023-04-25),

Title: The Innovative Contributions of Marshall Lee Morningstar

Introduction

Marshall Lee Morningstar is a notable inventor based in Framingham, MA, with a significant portfolio of eight patents. His work primarily focuses on neuroactive steroids and their applications in treating central nervous system (CNS) disorders. Morningstar's innovative contributions have the potential to impact the pharmaceutical industry significantly.

Latest Patents

Among his latest patents, Morningstar has developed compounds that include a specific formula designed for pharmaceutical use. These compounds are characterized by a complex structure, where various components are defined to enhance their effectiveness. The patents detail methods of using these compounds in treating CNS-related disorders, showcasing his commitment to advancing medical science.

Career Highlights

Marshall Lee Morningstar is currently associated with Sage Therapeutics, Inc., a company known for its focus on developing innovative treatments for CNS disorders. His role at Sage Therapeutics allows him to contribute to groundbreaking research and development in the field of neuroactive steroids.

Collaborations

Throughout his career, Morningstar has collaborated with esteemed colleagues such as Francesco Gerald Salituro and Maria Jesus Blanco-Pillado. These collaborations have fostered an environment of innovation and shared knowledge, further enhancing the impact of their collective work.

Conclusion

Marshall Lee Morningstar's contributions to the field of neuroactive steroids exemplify the importance of innovation in medicine. His patents and collaborations reflect a dedication to improving treatments for CNS disorders, marking him as a significant figure in the realm of pharmaceutical inventions.

Profile summary based on public USPTO records.